Related Experiment Video
Updated: Aug 20, 2025

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Central laboratory and point-of-care cardiac marker testing capacity of tertiary hospitals in Nigeria - a multicenter
Ijeoma Angela Meka1, Ochuko Otokunefor2, Asuquo Ene3
1University of Nigeria Faculty of Medical Sciences, Chemical Pathology.
Insights
Cardiac marker testing capacity in Nigerian tertiary hospitals is insufficient. Only 55.88% of hospitals have functional facilities, highlighting a critical need for improvement in diagnosing cardiovascular diseases like Acute Coronary Syndrome (ACS).
Area of Science:
- Clinical Diagnostics
- Cardiovascular Medicine
- Healthcare Management
Background:
- Cardiovascular diseases (CVDs) are leading causes of illness and death globally.
- Cardiac marker testing is crucial for diagnosing Acute Coronary Syndrome (ACS).
- Tertiary hospitals, particularly teaching hospitals, are expected to provide advanced cardiac diagnostics.
Purpose of the Study:
- To assess the availability and functionality of central laboratory and point-of-care cardiac marker testing services.
- To determine the cardiac marker testing capacity in Nigerian tertiary hospitals.
- To identify barriers to establishing comprehensive cardiac marker testing services.
Main Methods:
- A cross-sectional survey was conducted among government-owned tertiary hospitals in Nigeria.
- Data were collected using semi-structured, self-administered questionnaires.
- Statistical analysis was performed using Stata version 13.
Main Results:
- Out of 34 participating hospitals, only 19 (55.88%) possessed functional cardiac marker testing facilities (point-of-care, central laboratory, or both).
- The primary reason for lacking facilities was the inability to fund equipment procurement.
- In hospitals with testing capabilities, central laboratories predominantly housed the testing devices.
Conclusions:
- The capacity for cardiac marker testing in Nigerian tertiary hospitals is currently inadequate for both point-of-care and central laboratory services.
- Significant improvements are required to enhance diagnostic capabilities for patients requiring cardiac marker evaluation.
- Addressing funding gaps for equipment is essential to expand testing services.
Background:
Cardiovascular diseases are major contributors to morbidity and mortality. It is generally recognized that cardiac markers are of particular benefit in the evaluation of patients with suspected Acute Coronary Syndrome (ACS). Tertiary hospitals, mainly teaching hospitals, are expected to be optimally equipped to offer these services. The study therefore aimed at determining the central laboratory and point-of-care cardiac marker testing capacity of tertiary hospitals in Nigeria.
Method:
A cross-sectional survey was carried out in government-owned tertiary hospitals in Nigeria. Data were collected using semi-structured self-administered questionnaires, and analyzed using Stata version 13 (Stata Corp., USA).
Results:
A total of 34 hospitals participated in the study. The mean (SD) age of respondents was 43.68 (5.2) years. A total of 19 (55.88%) hospitals were found to have a functional cardiac marker testing facility, either in the form of point-of-care, central laboratory testing or both. Of those without a facility, lack of funds to procure equipment was the major reason given. In hospitals with a testing facility, most testing devices were located in the Central laboratory.
Conclusion:
Cardiac marker testing capacity of tertiary hospitals in Nigeria, both in the form of point-of-care and central laboratory testing, was found to be barely adequate. Improvement is needed in this area for better diagnosis and evaluation of patients who need the tests.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview